Bangkok Dusit Medical Services (BDMS): Private Hospital Network Economics

Questions this report answers

What is BDMS's FY2024 financial trajectory? Per the FY2024 56-1, total revenue was THB 109.35B🔒 (+7.09%🔒 YoY), hospital revenue THB 103.68B🔒 (+7%🔒 YoY), and net profit THB 15,987M🔒 (+11%🔒 YoY). EBITDA margin reached 24.3%🔒 with 4Q24 at 24.9%🔒. The board declared a THB 0.75🔒/share dividend for 2024. Q2 2025 sustained the trajectory at +4%🔒 YoY revenue and +5%🔒 YoY net profit per Kaohoon. International patient revenue grew +11%🔒 YoY in 2024, with Qatari patient revenue specifically +49%🔒 YoY — the headline-growth cohort.^{[1, 2, 5]}

How is the BDMS hospital network structured? Year-end 2025 composition is 60 hospitals and approximately 9,384 structured beds per the BDMS investor-network presentation. Brand stratification: Bangkok Hospital is the premium tier with 31 hospitals and 4,616 beds; Samitivej runs 8 hospitals / 1,693 beds; Phyathai 7 / 1,434; Paolo 7 / 807; BNH 1 / 115; Royal International 2 / 133; Local 4 / 602. The brand stratification supports a clear pricing-and-positioning ladder from Bangkok Hospital and Samitivej (premium international) through Phyathai (upper-mid Thai) to Paolo and BNH (mid-tier Thai-domestic).^[3]

How material is the international-patient business and Middle East corridor? International patient mix reached 29%🔒 of BDMS revenue in 2024 (up from 18-21%🔒 during 2020-2022 per KKP Securities). Middle East specifically contributes ~5%🔒 of total BDMS revenue. By comparison, Bumrungrad's foreign-patient mix is 67%🔒 with Middle East 25-30%🔒 of revenue — a much more concentrated international model. BDMS's mix is structurally Thai-domestic-anchored with international as the high-growth marginal driver. The Qatari patient revenue +49%🔒 YoY 2024 is the standout cohort momentum signal.^{[6, 2, 4]}

What is the FY2025 capacity-add plan and TAT medical-tourism context? FY2025 capacity adds per Bangkok Post: Samitivej International Children's Hospital (103 beds, March 2025), Bangkok Hospital Chiang Mai (90 beds, May 2025), Phyathai Bowin (220 beds, July 2025), and Bangkok Hospital Khao Yai (71 beds, November 2025). The TAT 2025-2026 medical-tourism target is THB 125B🔒 from approximately 580,000 medical tourists (1.74%🔒 of international arrivals); average length-of-stay for health tourists is 12.5 days in 2024 per Nation Thailand. The capacity additions are aligned to international-patient-growth absorption with Children's Hospital (Samitivej) and provincial-tourist-anchor adds (Chiang Mai, Khao Yai).^{[7, 8]}

Executive summary

Bangkok Dusit Medical Services (SET: BDMS) is Thailand's largest private hospital chain, operating 60 hospitals and approximately 9,384 structured beds at year-end 2025 across Bangkok Hospital, Samitivej, Phyathai, Paolo, BNH, Royal International, and Local brand families. FY2024 financials confirm structural strength: revenue THB 109.35B🔒 (+7.09%🔒 YoY), hospital revenue THB 103.68B🔒 (+7%🔒 YoY), net profit THB 15,987M🔒 (+11%🔒 YoY), and an EBITDA margin of 24.3%🔒 per the 56-1 and FY2024 newsletter. The brand stratification — Bangkok Hospital and Samitivej as the premium international-patient anchor; Phyathai and Paolo as upper-mid Thai-domestic — supports the cleanest Thai-listed premium-tier hospital exposure.^{[1, 2, 3]}

International-patient growth is the structural margin lever. International revenue grew +11%🔒 YoY in 2024, with Qatari patient revenue +49%🔒 YoY as the headline cohort. International patient mix reached 29%🔒 of BDMS revenue in 2024, up from 18-21%🔒 during 2020-2022 per KKP Securities — a structural rotation post-COVID. Middle East specifically contributes ~5%🔒 of total revenue. The TAT 2025-2026 target of THB 125B🔒 from ~580,000 medical tourists supports the structural-demand thesis; 12.5-day average length-of-stay reflects the high-acuity rather than wellness-tourism mix that anchors BDMS revenue per visit.^{[6, 2, 8]}

FY2025 capacity expansion is aligned to absorb international-patient growth. Four new openings totalling 484 beds: Samitivej International Children's Hospital (103 beds, Mar 2025), Bangkok Hospital Chiang Mai (90 beds, May 2025), Phyathai Bowin (220 beds, Jul 2025), and Bangkok Hospital Khao Yai (71 beds, Nov 2025). The Children's Hospital addresses the family-tourism-medical cohort; Chiang Mai and Khao Yai capture provincial-tourist anchors. TRIS Rating's BDMS credit rationale cites international patient revenue growth and Qatari / Chinese cohort momentum, network scale, and leverage profile as the rating supports — confirming the structural-fundamental view.^{[7, 10]}

BDMS brand network composition (year-end 2025)